S Clift

4.9k total citations · 1 hit paper
30 papers, 3.7k citations indexed

About

S Clift is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, S Clift has authored 30 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Genetics and 9 papers in Oncology. Recurrent topics in S Clift's work include Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). S Clift is often cited by papers focused on Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). S Clift collaborates with scholars based in United States, Netherlands and Sweden. S Clift's co-authors include Ronald M. Krauss, Edward M. Rubin, Elizabeth A. Spangler, Judy G. Verstuyft, David W. Martin, L. Cohen, Lorraine J. Gudas, Richard C. Mulligan, E M Rubin and Brian Y. Ishida and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

S Clift

30 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI

1991 820 citations Edward M. Rubin, Ronald M. Krauss et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Clift United States	25	1.7k	1.3k	1.1k	843	836	30	3.7k
Keith R. Marotti United States	19	1.3k 0.8×	702 0.5×	311 0.3×	441 0.5×	406 0.5×	36	2.8k
Iafa Keydar Israel	30	1.9k 1.1×	1.1k 0.9×	1.3k 1.3×	615 0.7×	207 0.2×	56	3.6k
Debanjan Dhar United States	22	1.2k 0.7×	641 0.5×	883 0.8×	532 0.6×	348 0.4×	32	3.1k
Ann L. White United States	26	1.1k 0.7×	834 0.7×	761 0.7×	128 0.2×	1.1k 1.3×	48	2.9k
Hiroyuki Kuramoto Japan	29	1.2k 0.7×	379 0.3×	661 0.6×	654 0.8×	208 0.2×	146	3.1k
Ian Spendlove United Kingdom	32	1.3k 0.8×	1.4k 1.1×	983 0.9×	128 0.2×	194 0.2×	74	3.3k
Hitoshi Akedo Japan	31	2.1k 1.3×	549 0.4×	793 0.8×	179 0.2×	412 0.5×	96	3.5k
Hidetoshi Sumimoto Japan	28	1.7k 1.0×	1.1k 0.8×	1.1k 1.1×	413 0.5×	84 0.1×	55	3.1k
D Kufe United States	35	3.1k 1.8×	994 0.8×	1.5k 1.4×	423 0.5×	232 0.3×	78	4.7k
Sajjad A. Qureshi United States	22	1.2k 0.7×	1.1k 0.8×	1.3k 1.2×	200 0.2×	253 0.3×	34	2.5k

Countries citing papers authored by S Clift

Since Specialization

Citations

This map shows the geographic impact of S Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Clift more than expected).

Fields of papers citing papers by S Clift

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Clift. The network helps show where S Clift may publish in the future.

Co-authorship network of co-authors of S Clift

This figure shows the co-authorship network connecting the top 25 collaborators of S Clift. A scholar is included among the top collaborators of S Clift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Clift. S Clift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clift, S, et al.. (2023). Lung pathology of natural Babesia rossi infection in dogs. Journal of the South African Veterinary Association. 94(1). 59–69. 2 indexed citations

Luiten, Rosalie M., Esther W. M. Kueter, Wolter J. Mooi, et al.. (2005). Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients. Journal of Clinical Oncology. 23(35). 8978–8991. 90 indexed citations

Nelson, William G., Jonathan W. Simons, Bahar Mikhak, et al.. (2000). Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemotherapy and Pharmacology. 46(S1). S67–S72. 62 indexed citations

Simons, Jonathan W., Bahar Mikhak, Angelo M. De Marzo, et al.. (1999). Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.. PubMed. 59(20). 5160–8. 375 indexed citations

Baccala, Angelo A., Hua Zhong, S Clift, et al.. (1998). Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer. Urology. 51(2). 327–332. 23 indexed citations

Simons, J.W., Elizabeth M. Jaffee, William G. Nelson, et al.. (1998). Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer. The Journal of Urology. 159(2S). 617–618. 61 indexed citations

Rankin, Elaine M., et al.. (1997). Immunomodulation following vaccination with autologous, GM-CSF transduced and irradiated tumor cells in patients with advanced melanoma. Immunology Letters. 56. 166–166. 1 indexed citations

Dwarki, Varavani, Paula Belloni, Tarlochan Nijjar, et al.. (1995). Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.. Proceedings of the National Academy of Sciences. 92(4). 1023–1027. 94 indexed citations

Schultz, Joshua R., Enhao Gong, M R McCall, et al.. (1992). Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.. Journal of Biological Chemistry. 267(30). 21630–21636. 91 indexed citations

10.

Rubin, Edward M., H. Ewa Witkowska, Elizabeth A. Spangler, et al.. (1991). Hypoxia-induced in vivo sickling of transgenic mouse red cells.. Journal of Clinical Investigation. 87(2). 639–647. 49 indexed citations

11.

Rubin, Edward M., Ronald M. Krauss, Elizabeth A. Spangler, Judy G. Verstuyft, & S Clift. (1991). Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353(6341). 265–267. 820 indexed citations breakdown →

12.

Clift, S, et al.. (1989). Tissue-Specific Regulation of Human α ₁ -Antitrypsin Gene Expression in Transgenic Mice. DNA. 8(2). 101–108. 25 indexed citations

13.

Carlson, Joyce, Brianne B. Rogers, R N Sifers, et al.. (1989). Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.. Journal of Clinical Investigation. 83(4). 1183–1190. 243 indexed citations

14.

Jones, William K., et al.. (1985). The rat casein multigene family. Fine structure and evolution of the beta-casein gene.. Journal of Biological Chemistry. 260(11). 7042–7050. 108 indexed citations

15.

Eriksson, S., Lorraine J. Gudas, S Clift, et al.. (1981). Evidence for genetically independent allosteric regulatory domains of the protein M1 subunit of mouse ribonucleotide reductase.. Journal of Biological Chemistry. 256(19). 10193–10197. 37 indexed citations

16.

Eriksson, S., Lorraine J. Gudas, Buddy Ullman, S Clift, & D. W. Martin. (1981). DeoxyATP-resistant ribonucleotide reductase of mutant mouse lymphoma cells. Evidence for heterozygosity for the protein M1 subunits.. Journal of Biological Chemistry. 256(19). 10184–10188. 23 indexed citations

17.

Ullman, Buddy, et al.. (1980). Alterations in deoxyribonucleotide metabolism in cultured cells with ribonucleotide reductase activities refractory to feedback inhibition by 2'-deoxyadenosine triphosphate.. Journal of Biological Chemistry. 255(17). 8308–8314. 58 indexed citations

18.

Ullman, Buddy, Barbara Levinson, Lorraine J. Gudas, et al.. (1980). Abnormal Regulation of Purine Metabolism in a Cultured Mouse T-Cell Lymphoma Mutant Partially Deficient in Adenylosuccinate Synthetase. Advances in experimental medicine and biology. 122A. 375–386. 1 indexed citations

19.

Martin, Gail R., Charles J. Epstein, Georgianne Tucker, et al.. (1978). X–chromosome inactivation during differentiation of female teratocarcinoma stem cells in vitro. Nature. 271(5643). 329–333. 116 indexed citations

20.

Gudas, Lorraine J., et al.. (1978). Characterization of mutant subunits of human purine nucleoside phosphorylase.. Journal of Biological Chemistry. 253(24). 8916–8924. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact